About Sovereign Peptides

Cellular control

The apparent authority in this name attracted me. A sovereign rules; a peptide is often described as though it can issue a similarly clear instruction to damaged tissue. The experiments become more interesting when that authority gets qualified.

The KPV result in MC1R-deficient mice is a good example. An inflammation effect persisted despite a receptor deficiency. I want those remaining mechanisms pinned down. With full-length thymosin beta-4 in rats, the higher tested dose supplied no significant neurological benefit. The obvious story about more signal producing more repair left me doubtful.

These are the questions that give Sovereign Peptides a reason to exist: which molecule was tested, which part of a living system responded, and what changed when a condition changed? An experiment that constrains an impressive claim has my affection. It gives the next investigation something definite to work on.

Personal inquiry

At Sovereign Peptides, my subject is the published research on BPC-157, TB-500, GHK-Cu and KPV. The site offers essays about those experiments, a comparison and a reading list. The biology supplies my interest; this site cannot examine a person or decide on a treatment.

Nothing here constitutes medical advice. A condition, a medicine and a person's health history require a clinician's assessment. Choosing a peptide, a dose or a schedule for anyone exceeds my role here, and correspondence about this site is for factual corrections rather than personal care.

These papers contain both encouraging findings and large unresolved questions. That combination makes the boundary essential to me. Describing a preclinical effect accurately takes work; determining whether a treatment helps people safely takes clinical evidence. My appetite for that evidence includes results that disappoint expectations.

The references collect the research discussed here. If a population, an outcome or a molecule has escaped my scrutiny, the contact page gives the correction address.